Literature DB >> 10335682

Age at natural menopause and risk of cardiovascular disease.

F B Hu1, F Grodstein, C H Hennekens, G A Colditz, M Johnson, J E Manson, B Rosner, M J Stampfer.   

Abstract

BACKGROUND: Early natural menopause has been postulated to increase the risk of cardiovascular disease.
OBJECTIVE: To examine the relation of age at natural menopause with risk of coronary heart disease (CHD) and stroke in the Nurses' Health Study.
METHODS: Analysis was restricted to 35 616 naturally postmenopausal women who never used estrogen replacement therapy and with no diagnosed cardiovascular disease at baseline, followed up from 1976 to 1994. Information on menopausal status, age at menopause, and other risk factors was obtained in 1976 and updated every 2 years by mailed questionnaires.
RESULTS: During 354326 person-years of follow-up, we documented 757 incident cases of CHD and 350 incident cases of stroke. After adjusting for age, smoking status, and other cardiovascular risk factors, the relative risks (RRs) across categories of age at natural menopause (<40, 40-44, 45-49, 50-54, and > or = 55 years) were 1.53, 1.42, 1.10, 1.00 (reference), and 0.95, respectively; the RR for each 1-year decrease in age at natural menopause was 1.03 (95% confidence interval, 1.01-1.05). Elevated risk with younger age at menopause was observed among current smokers (RR, 1.04 [95% CI, 1.01-1.07] for each 1-year decrease in age at natural menopause) but not among never smokers (RR, 1.00; 95% CI, 0.96-1.04). Age at natural menopause was not significantly associated with ischemic stroke (RR, 1.01; 95% CI, 0.97-1.04) or hemorrhagic stroke (RR, 1.03; 95% CI, 0.97-1.10).
CONCLUSIONS: We observed an overall significant association between younger age at menopause and higher risk of CHD among women who experienced natural menopause and never used hormone therapy. This increased risk was observed among current smokers but not among never smokers. The apparent elevated risk of CHD with decreased age at natural menopause among smokers might reflect residual confounding by smoking.

Entities:  

Mesh:

Year:  1999        PMID: 10335682     DOI: 10.1001/archinte.159.10.1061

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  113 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Conflicts of interest in medicine and science.

Authors:  Lois Rogers
Journal:  Eur Heart J       Date:  2012-04       Impact factor: 29.983

Review 3.  Cardiovascular disease and primary ovarian insufficiency.

Authors:  Melissa Wellons
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

4.  Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among women.

Authors:  Yanping Li; Yang Hu; Sylvia H Ley; Swapnil Rajpathak; Frank B Hu
Journal:  Diabetes Care       Date:  2014-08-22       Impact factor: 19.112

5.  Age at natural menopause and risk of ischemic stroke: the Framingham heart study.

Authors:  Lynda D Lisabeth; Alexa S Beiser; Devin L Brown; Joanne M Murabito; Margaret Kelly-Hayes; Philip A Wolf
Journal:  Stroke       Date:  2009-02-20       Impact factor: 7.914

6.  Longitudinal study of the inception of perimenopause in relation to lifetime history of sexual or physical violence.

Authors:  Jenifer E Allsworth; Sally Zierler; Kate L Lapane; Nancy Krieger; Joseph W Hogan; Bernard L Harlow
Journal:  J Epidemiol Community Health       Date:  2004-11       Impact factor: 3.710

7.  Short term exposure to di-n-butyl phthalate (DBP) disrupts ovarian function in young CD-1 mice.

Authors:  Nivedita Sen; Xiaosong Liu; Zelieann R Craig
Journal:  Reprod Toxicol       Date:  2015-03-09       Impact factor: 3.143

8.  Loss of estrogen receptor beta decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice.

Authors:  Muthuvel Jayachandran; Claudia C Preston; Larry W Hunter; Arshad Jahangir; Whyte G Owen; Kenneth S Korach; Virginia M Miller
Journal:  Age (Dordr)       Date:  2009-11-12

9.  Antral follicle count predicts natural menopause in a population-based sample: the Coronary Artery Risk Development in Young Adults Women's Study.

Authors:  Melissa F Wellons; Gordon Wright Bates; Pamela J Schreiner; David S Siscovick; Barbara Sternfeld; Cora E Lewis
Journal:  Menopause       Date:  2013-08       Impact factor: 2.953

10.  Di-n-butyl phthalate disrupts the expression of genes involved in cell cycle and apoptotic pathways in mouse ovarian antral follicles.

Authors:  Zelieann R Craig; Patrick R Hannon; Wei Wang; Ayelet Ziv-Gal; Jodi A Flaws
Journal:  Biol Reprod       Date:  2013-01-31       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.